Related Articles
Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases
Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-small‑cell lung cancer
Non‑small cell lung cancer with multiple brain metastases remains relapse‑free for more than 13 years: A case report
Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients
Prognostic factors and skeletal‑related events in patients with bone metastasis from gastric cancer